Immunotherapy in Prostate Cancer
Journal Title: The Bulletin of Urooncology - Year 2009, Vol 18, Issue 2
Abstract
In recent years, immunotherapy has become an important treatment alternative in the treatment of many cancers. Research on immunotherapy in prostate cancer has been accelerated by obtaining Food and Drug Administration (FDA) approval of sipuleucel-T for asymptomatic or minimal symptomatic metastatic castration-resistant prostate cancer (CRPC). Despite all these developments, the patients in whom these agents should be used, sequential use and combination strategies remain unclear. In this review, mechanisms of action and survival outcomes of different immunotherapeutic agents and therapeutic cancer vaccines in mCRPC are discussed.
Authors and Affiliations
Deniz Bolat MD, Ayfer Haydaroğlu,
Keywords
Related Articles
- EP ID EP48741
- DOI 10.4274/uob.galenos.2018.1142
- Views 297
- Downloads 0
Effect of High-dose Ascorbic Acid on Prostate Cancer Cells and Angiogenesis
Objective: Ascorbic acid (AA), at physiological concentrations, is a well known anti-oxidant but, at higher concentrations, it can be selectively toxic to cancer cells. Controversial data have shown that administration o...
Multiparametric MRI Fusion-guided Biopsy for the Diagnosis of Prostate Cancer: Results of the First 100 Consecutive Patients
Objective: Our aim was to compare prostate cancer detection rates according to International Society of Urological Pathology (ISUP) grade group (GG) among magnetic resonance imaging (MRI)-targeted biopsies (TBx), systema...
Experiences of Laparoscopic Partial Nephrectomy for T1a Kidney Tumours: Results of Two Hundred and Fifteen Patients
Objective: The best therapeutic option for renal tumours smaller than 7 cm is partial nephrectomy. The aim of this study was to compare the positive surgical margin (PSM) rates, recurrence rates and oncological outcomes...
Predictive Value of Duration and Frequency of Macroscopic Haematuria for Stage, Prognosis and Recurrence in Bladder Cancer Patients
Objective: We aimed to investigate the predictive value of duration and frequency of macroscopic haematuria for the stage, prognosis and recurrence rates in primary bladder cancer. Materials and Methods: We retrospectiv...
The Effect of Framingham Score on the Oncological Outcomes in Localized (T1-T2 Stage) Renal Cell Carcinoma Patients
Objective: To evaluate the effect of cardiovascular disease risk on local recurrence, distant metastasis development and cancer-specific survival in patients with localized (stage 1 and 2) renal cell carcinoma (RCC). Ma...